COX4I1 and Parkinson disease: Most potential biomarkers, including NDUFS1 (NADH: Ubiquinone oxidoreductase core subunit S1) and COX4I1 (Cytochrome C oxidase subunit 4I1), have been extracted while cross-platform datasets are described suggesting significant monitoring among prognostic predictors and novel therapeutics challenges related to PD [24].